insights_auto
Bakit tumaas ang TNDM 2.11%?
Tingnan ang Higit pang Detalyechevron_right
TNDM:NASDAQ
Tandem Diabetes Care Inc
$16.45
arrow_upward
+2.11%(+0.34) 1D
$16.45
0.00% (0.00)
bedtimePagkalipas ng oras ng trabaho
Sarado: Okt 12, 4:00:01 PM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa TNDM...
Buksan
$16.11
Mataas
$16.91
Mababa
$15.86
Mkt. cap
1.14B
Avg. na dami
2.05M
Dami
1.58M
Mataas nang 52-wk
$29.65
Mababa nang 52-wk
$12.26
EPS
-$0.93
Beta
1.66
Mga natitirang share
69.58M
Bilang ng mga empleyado
2K
Buksan
$16.11
Mataas
$16.91
Mababa
$15.86
Mkt. cap
1.14B
Avg. na dami
2.05M
Dami
1.58M
Mataas nang 52-wk
$29.65
Mababa nang 52-wk
$12.26
EPS
-$0.93
Beta
1.66
Mga natitirang share
69.58M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
Benzinga
·
13 oras ang nakalipas
Tandem Diabetes Care Q2 2026 Earnings Call Transcript
Profile
Tandem Diabetes Care, Inc. is an American medical-device company that develops and markets insulin pumps, automated insulin delivery systems and diabetes-management software. Headquartered in San Diego, California, its principal pump platforms are the t:slim X2 and Tandem Mobi, both of which use the company's Control-IQ+ software with compatible continuous glucose monitors.
Tandem was founded in 2006 and introduced its first pump, the touchscreen t:slim, in 2012. The company became publicly traded on the Nasdaq in 2013. By the end of 2025 it reported an in-warranty user base of nearly 500,000 people in more than 25 countries and annual sales of $1.015 billion. Wikipedia
Tungkol sa Tandem Diabetes Care Inc